like-icon -ArticlesDrugs and Droids-Harnessing the Potential of AI in Drug Discovery September 27, 2023Read more
like-icon -NewsEnzolytics, Inc. announces the execution of the binding business combination agreement for the sale of Biogenysis, Inc. (“BGEN”) and Virogentics Inc. (“VIRO”), the operating subsidiaries of Enzolytics Inc. September 18, 2023Read more
